Smith & Nephew PLC (SN.)

Industry Medical Devices


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1,196.00p

Buy

1,197.00p

arrow-down-9.50p (-0.79%)

Prices updated at 16 Dec 2025, 14:46 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Smith & Nephew PLC designs, manufactures, and markets orthopedic devices and wound-care solutions. Its products include knee replacements, hip implants, nails, fixation devices, arthroscopy tools and others.

Income statement

20232024
5,549m5,810m
3,819m4,046m
620m860m
11.1714.80
263m412m
956m1,221m
Sales, General and administrative2,602m2,652m
Interest expenses139m168m
Provision for income taxes27m86m
Operating expenses3,199m3,186m
Income before taxes290m498m
Net income available to common shareholders263m412m
0.3020.472
Net interest income-105m-149m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.3010.47
Free cash flow per share0.01980.2747
Book value/share4.71434.7489
Debt equity ratio0.4445080.618803

Balance sheet

20232024
Current assets4,030m4,421m
Current liabilities2,271m1,531m
Total capital7,392m8,388m
Total debt3,084m3,321m
Total equity5,217m5,265m
Total non current liabilities--
Loans2,175m3,123m
Total assets9,987m10,354m
Total liabilities--
Cash and cash equivalents302m619m
Common stock872m873m

Cash flow

20232024
Cash at beginning of period344m300m
Cash dividends paid-327m-327m
181m606m
Investments (gains) losses-448m-569m
300m617m
Net income--
608m987m
-427m-381m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.